MGRX

Mangoceuticals, Inc. Common Stock
Data: 2026-01-30
$0.361
Price
-2.98%
Change
$6.15
52W High
$0.3513
52W Low

Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.

Quick Stats
Jan 30, 2026

48.5

AI Score

HOLD

0.49

Volume Ratio

Mar 19, 2026

Next Earnings

10

+ve Days (30d)

20

-ve Days (30d)

MGRX Stock Summary

Last updated Jan 30, 2026

MGRX is currently trading at $0.361, positioned below its 200-day moving average of $1.67, suggesting bearish momentum. The stock has a 52-week range of $0.3513 to $6.15.

Technical Analysis: The 50-day moving average stands at $0.88, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 24.652, suggesting the stock is oversold and potentially undervalued.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.305, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates MGRX at 48.5/100 with a HOLD recommendation.

MGRX (Mangoceuticals, Inc. Common Stock) Indicators

Last updated Jan 30, 2026

Indicator Value
RSI(14) 24.652
CMF (20) -0.305
ROC (10) -45.641
ADX (14) 26.898
Indicator Value
MACD (12,26,9) -0.162
AROONOSC (14) -100.0
WILLAMS %R (14) -97.972
MFI (14) 0.0
MGRX Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

MGRX Price vs Max Options Open Interest
MGRX Max Change In Options Open Interest

MGRX Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

MGRX Daily Out of Money Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

MGRX Daily In the Money Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

MGRX Most Active Options by Volume(near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Mangoceuticals, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

MGRX Moving Averages Analysis

MGRX (Mangoceuticals, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Jan 30, 2026

Days MA
10 0.49
20 0.65
30 0.71
50 0.88
100 1.53
200 1.67

MGRX Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) --
Market Cap ($) 7.0 million
Earnings/Share ($) -2.72
Net Proft Margin (%) 0
Dividend/Share ($) --
EPS Estimate Current Year ($) 0
EPS Estimate Next Year ($) 0
WallStreet Target Price ($) --
Most Recent Quarter